Overview

rhPTH Therapy for Low Turnover Bone Fragility

Status:
Terminated

Trial end date:
2011-09-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine how treatment with a new medication, recombinant human parathyroid hormone (rhPTH) affects calcium balance and bone strength.

Phase:

Phase 1

Details

Lead Sponsor:

University of Chicago

Treatments:

Parathyroid Hormone